Notice ID AAQ230_AMSIS_RFI_1022020
“The FAA is currently analyzing alternatives on how to most effectively accomplish completion of the Aerospace Medicine Safety Information System (AMSIS) program. The FAA has an existing contract with Tetra Tech, AMT, for AMSIS Phase 1 (Drug Abatement (Release 1) and airmen certification and Air Traffic Controller (ATC) clearance (Release 2), and AMSIS Phase 2, which could be contracted for separately as an option, if doing so were determined to be advantageous to the Government. Phase 1, Release 1 is being completed December 2020 and Release 2 is planned for start of development in CY 2021 with completion early in CY 2022.”
“The AMSIS Architecture has been developed and serves as a basis for Release 1, Release 2 and portions of Phase 2. The architecture is built upon Commercial-off-the-Shelf (COTS) and Government Provided COTS systems integrated through AMSIS development. Upon delivery and acceptance of Release 1, the Drug Abatement software and the system architecture will be owned by the Government. The FAA is still finalizing Phase 2 requirements.”
“The Agency is researching the best alternative(s) to complete the total AMSIS system. The continuation of work could be built on the system architecture developed as part of Phase 1 and as a basis for Phase 2 functionality. The FAA is performing its due diligence on the acquisition strategy, approach, and actions for meeting the remaining requirements.”
“AMSIS will provide an aerospace medical information network that integrates critical, security sensitive medical information generated from geographically distributed national and international locations. AMSIS critical data may be used for regulatory enforcement purposes in addition to interfacing with a variety of agency mission related databases. The AMSIS program provides for the procurement of services for the design, development and deployment of a new information system.
The program objectives include providing:
- Automated data processing to improve productivity for the collection/storage, review, and analysis of sensitive medical information for Airmen and ATCS;
- Tools for AAM to analyze resulting information to make risk-based policy decisions;
- Data access through secured methods that are easily accessible without compromising data security, while enabling appropriately authorized government personnel to access the information for decision making;
- Operational support to FAA and National Transportation Safety Board (NTSB) accident investigators with toxicology and autopsy information;
- Financial systems to support budgeting of program resources and invoicing and payment associated with medical investigations
The system will:
- Improve the processes for comprehensive access to data, improving timeliness and accuracy (such as e-authentication) while reducing paper-based correspondence.
- Enable more effective collaboration within the aviation community and among properly authorized personnel, designees, and applicants.
- Provide improved automated handling and analysis of biological specimens from victims of fatal aircraft accidents and acquisition of autopsy information for distribution to accident investigators and medical researchers.